Prostate Cancer

Cancer remains the main use of Vilac Plus over the world since the publication of 3 clinical trials : Brain Tumor and Lung Cancer in 2006, then Cervical Cancer in 2007. The antiradical effectiveness of Vilac Plus had already been proved In Vitro (KRL Test).

Dr Noel Jové, La Paz

Doctor Noel Jové is a pediatric surgeon, pediatric urology.

Himself was suffering from a prostate cancer with bones metastasis. He talks about the effects of Vilac Plus®. (more…)